| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41380-020-0786-5 |
| P698 | PubMed publication ID | 32504049 |
| P50 | author | Mark Rasenick | Q30323429 |
| Roy H. Perlis | Q88592183 | ||
| P2093 | author name string | Steven D Sheridan | |
| Jiang-Zhou Yu | |||
| Jennifer Wang | |||
| P2860 | cites work | A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. | Q27860879 |
| ω-3 Fatty acids for major depressive disorder in adults: an abridged Cochrane review | Q28076799 | ||
| Altered functional protein networks in the prefrontal cortex and amygdala of victims of suicide | Q28485508 | ||
| Chronic treatment with escitalopram but not R-citalopram translocates Galpha(s) from lipid raft domains and potentiates adenylyl cyclase: a 5-hydroxytryptamine transporter-independent action of this antidepressant compound | Q28583883 | ||
| NMDAR-independent, cAMP-dependent antidepressant actions of ketamine. | Q55456849 | ||
| Pharmacological characterization of BDNF promoters I, II and IV reveals that serotonin and norepinephrine input is sufficient for transcription activation | Q60620847 | ||
| Inhibition of Necroptosis Rescues SAH-Induced Synaptic Impairments in Hippocampus via CREB-BDNF Pathway | Q60919515 | ||
| Anxiolytic- and Antidepressant-Like Effects of Fish Oil-Enriched Diet in Brain-Derived Neurotrophic Factor Deficient Mice | Q60938818 | ||
| Treatment-resistant depression: problematic illness or a problem in our approach? | Q61440284 | ||
| Prognosis and improved outcomes in major depression: a review | Q64082982 | ||
| A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder | Q67977523 | ||
| Administration of a cAMP phosphodiesterase 4 inhibitor enhances antidepressant-induction of BDNF mRNA in rat hippocampus | Q73349588 | ||
| A morphometric study of glia and neurons in the anterior cingulate cortex in mood disorder | Q83881077 | ||
| Assessing the adequacy of past antidepressant trials: a clinician's guide to the antidepressant treatment response questionnaire | Q84908308 | ||
| Alterations in Serum BDNF and GDNF Levels after 12 Weeks of Antidepressant Treatment in Female Outpatients with Major Depressive Disorder | Q89264058 | ||
| Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders | Q90231351 | ||
| Docosahexaenoic Acid (DHA) Induced Morphological Differentiation of Astrocytes Is Associated with Transcriptional Upregulation and Endocytosis of β2-AR | Q90583406 | ||
| Omega-3 polyunsaturated fatty acids and reduction of depressive symptoms in older adults: A systematic review and meta-analysis | Q91108065 | ||
| Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning | Q91341535 | ||
| Brain eicosapentaenoic acid metabolism as a lead for novel therapeutics in major depression | Q91671390 | ||
| Efficacy of omega-3 PUFAs in depression: A meta-analysis | Q92431544 | ||
| Altered serotonergic circuitry in SSRI-resistant major depressive disorder patient-derived neurons | Q92564511 | ||
| Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia: A Randomized Clinical Trial | Q92649371 | ||
| Activation of WNT and CREB signaling pathways in human neuronal cells in response to the Omega-3 fatty acid docosahexaenoic acid (DHA) | Q92771832 | ||
| Monoamine neurocircuitry in depression and strategies for new treatments | Q30619239 | ||
| Characterization of a promoter for the human glial cell line-derived neurotrophic factor gene | Q30713688 | ||
| CREB couples neurotrophin signals to survival messages | Q33857179 | ||
| The {omega}-3 fatty acid eicosapentaenoic acid elicits cAMP generation in colonic epithelial cells via a "store-operated" mechanism | Q34178830 | ||
| Characterization of induced neural progenitors from skin fibroblasts by a novel combination of defined factors | Q34329654 | ||
| Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study | Q34468355 | ||
| Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression. | Q34523142 | ||
| N-3 poly-unsaturated fatty acids shift estrogen signaling to inhibit human breast cancer cell growth | Q34534676 | ||
| Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder | Q34588846 | ||
| Characterization of bipolar disorder patient-specific induced pluripotent stem cells from a family reveals neurodevelopmental and mRNA expression abnormalities | Q35634683 | ||
| Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole | Q35944981 | ||
| The role of CREB in depression and antidepressant treatment | Q36386532 | ||
| BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities. | Q36809785 | ||
| Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies | Q36813765 | ||
| Agomelatine: innovative pharmacological approach in depression | Q37587159 | ||
| Astrocytic abnormalities and global DNA methylation patterns in depression and suicide | Q37626767 | ||
| Polyunsaturated fatty acid associations with dopaminergic indices in major depressive disorder | Q37640767 | ||
| G-protein signaling, lipid rafts and the possible sites of action for the antidepressant effects of n-3 polyunsaturated fatty acids | Q38097891 | ||
| Concise review: Regulation of stem cell proliferation and differentiation by essential fatty acids and their metabolites. | Q38172830 | ||
| Role of glial cell line-derived neurotrophic factor in the pathogenesis and treatment of mood disorders | Q38720745 | ||
| An astroglial basis of major depressive disorder? An overview. | Q39186841 | ||
| Pluripotent stem cells in neuropsychiatric disorders | Q39189500 | ||
| Antidepressants induce acute CREB phosphorylation and CRE-mediated gene expression in glial cells: a possible contribution to GDNF production | Q40018904 | ||
| Chronic stress-induced disruption of the astrocyte network is driven by structural atrophy and not loss of astrocytes. | Q40099434 | ||
| Amitriptyline induces brain-derived neurotrophic factor (BDNF) mRNA expression through ERK-dependent modulation of multiple BDNF mRNA variants in primary cultured rat cortical astrocytes and microglia | Q40110323 | ||
| Increase by FK960, a novel cognitive enhancer, in glial cell line-derived neurotrophic factor production in cultured rat astrocytes | Q40546359 | ||
| The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description | Q41128285 | ||
| Regulation of forskolin interactions with type I, II, V, and VI adenylyl cyclases by Gs alpha | Q41431271 | ||
| Neuronal plasticity and neurotrophic factors in drug responses | Q41842609 | ||
| Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes | Q42752136 | ||
| PKA-CREB-BDNF signaling regulated long lasting antidepressant activities of Yueju but not ketamine | Q42774929 | ||
| Efficient generation of astrocytes from human pluripotent stem cells in defined conditions | Q43637863 | ||
| cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. | Q43954518 | ||
| Low glial numbers in the amygdala in major depressive disorder | Q44145406 | ||
| Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats | Q45056243 | ||
| Fish oil and depression: The skinny on fats | Q47280324 | ||
| N-3 polyunsaturated fatty acids and 17β-estradiol injection induce antidepressant-like effects through regulation of serotonergic neurotransmission in ovariectomized rats | Q48081932 | ||
| The role of 5-HT₁A receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: a possible antidepressant mechanism. | Q48124737 | ||
| Antidepressant administration modulates neural stem cell survival and serotoninergic differentiation through bcl-2. | Q48268006 | ||
| Potential role of brain-derived neurotrophic factor in omega-3 Fatty Acid supplementation to prevent posttraumatic distress after accidental injury: an open-label pilot study | Q49105599 | ||
| Anti-Depressant Fluoxetine Reveals its Therapeutic Effect Via Astrocytes. | Q55379563 | ||
| P921 | main subject | astrocyte | Q502961 |
| neural stem cell | Q2944097 | ||
| P577 | publication date | 2020-06-05 | |
| P1433 | published in | Molecular Psychiatry | Q6895973 |
| P1476 | title | N-3 polyunsaturated fatty acids promote astrocyte differentiation and neurotrophin production independent of cAMP in patient-derived neural stem cells |
| Q99572001 | The stress-Wnt-signaling axis: a hypothesis for attention-deficit hyperactivity disorder and therapy approaches | cites work | P2860 |
Search more.